cjc-1295 with dac + ipamorelin CJC 1295 No Blend | Research Peptide CJC-1295 no DAC + Ipamorelin

IGF1 increases hypothalamic and pituitary responses to GnRH, thereby potentially increasing LH and FSH secretion

It is studied in preclinical models to investigate pulsatile growth hormone secretion, muscle protein synthesis regulation, lipid metabolism effects, and GH/IGF-1 axis modulation

It is part of this practice's broader regenerative medicine philosophy not a standalone miracle therapy, but a precise tool for the right patient at the right stage of care

It is not intended to diagnose, treat, cure, or prevent any disease or medical condition, and must not be self-administered or applied to human subjects outside of a properly licensed, ethically approved, and institutionally supervised research environment

Increased GH and IGF-1 may indirectly modulate gonadotropins and sex steroids to support ovulation and spermatogenesis, so track LH, FSH, testosterone, estrogen, progesterone, and SHBG to assess response

This synchronized approach triggers an amplified, pulsatile release of endogenous growth hormone that far outpaces the mathematical sum of either compound evaluated in isolation